NovoCure
NVCR • NASDAQ
NovoCure is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Frank Leonard, with a market cap of $1.4B.
Market Cap$1.4B
Employees1.5K
CEOFrank Leonard
CountryJersey
Healthcare
Medical - Instruments & Supplies
Next EarningsApr 30, 2026 · In 6 daysBefore Market Open · Q1 2026
Financials
NovoCure FAQ
Common questions about NovoCure
NovoCure is scheduled to report earnings for Q1 2026 on April 30, 2026 before market open. Analysts estimate revenue of $167.8M.
NovoCure has approximately 1,453 employees.